meclizine has been researched along with Carcinoma, Hepatocellular in 1 studies
Meclizine: A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, Y | 1 |
| Chen, X | 1 |
| Wu, M | 1 |
| Zhu, W | 1 |
| Arslan, A | 1 |
| Takeda, S | 1 |
| Nguyen, MH | 1 |
| Majeti, R | 1 |
| Thomas, D | 1 |
| Zheng, M | 1 |
| Peltz, G | 1 |
1 other study available for meclizine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy.
Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Cell Survival; Drug Therapy, Combination; Female; G | 2020 |